Congenital Deafness
8
2
2
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
1 terminated out of 8 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Neuroanatomy of Reading in Congenital Deafness.
Natural History in Children Up to 16 Years with Mild to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes
A Phase I/II Clinical Trial with SENS-501 in Children Suffering from Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations
Genetic Feature of Congenital Hearing Loss in Chinese Population
Degenerative Consequences of Congenital Deafness
NGS Assessment of Congenitally Deafned Children and Neonatal Deafness Screnning
Natural History and Genetic Studies of Usher Syndrome
Clinical and Genetic Testing of Patients With Usher Syndrome